Search medications
MAKE AN APPOINTMENT
WHAT WE TREAT
PRICING
FAQs
DOCTOR
CONTACT

Medication help


Asthma
Inhalers
  • The three classes of inhaled asthma medications are beta agonists, corticosteroids, and antimuscarinics. Asthma inhalers contain one or a combination of these medications.
  • The table below contains PAP information for all the available asthma inhalers

Drug Manufacturer Ships to PAP info Application
Advair® diskus and HFA (fluticasone + salmeterol) GlaxoSmithKline Patient or other Link Link
Arnuity Ellipta® (Fluticasone) GlaxoSmithKline Patient or other Link Link
Asmanex® HFA and Twisthaler (mometasone) Merck Patient or doctor Link Link
Breo Ellipta® (fluticasone + vilanterol) GlaxoSmithKline Patient or other Link Link
Dulera® (mometasone + formoterol) Merck Patient or doctor Link Link
Flovent® Diskus and HFA (fluticasone) GlaxoSmithKline Patient or other Link Link
ProAir® HFA and RespiClick (albuterol) Teva Patient or doctor Link Link
Proventil® HFA (albuterol) Merck Patient or doctor Link Link
Pulmicort® Flexhaler (budesonide) AstraZeneca Patient or doctor Link Link
Qvar® (Beclomethasone) Teva Patient or doctor Link Link
Serevent® (salmeterol) GlaxoSmithKline Patient or other Link Link
Spiriva® handihaler and Respimat (tiotropium) Boehringer Ingelheim Patient Link Link
Symbicort® (budesonide + formoterol) AstraZeneca Patient or doctor Link Link
Ventolin® (albuterol) GlaxoSmithKline Patient or other Link Link

Atrial fibrillation
Anticoagulants
  • Atrial fibrillation is a heart arrhythmia that increases a person's risk of stroke. Most patients with atrial fibrillation take anticoagulants for stroke prevention.
  • There are 5 anticoagulants that can be used in atrial fibrillation. Four of them are newer medications that do not require frequent lab monitoring, but they have no generics and are expensive. Warfarin is an older anticoagulant that is cheap and effective, but it sometimes requires frequent lab monitoring (PT/INR), especially upon initiation. The table below gives the PAP information for the 4 newer drugs.

Drug Manufacturer Ships to PAP info Application
Apixaban (Eliquis®) Bristol-Myers Squibb Patient or doctor Link Link
Dabigatran (Pradaxa®) Boehringer Ingelheim Patient Link Link
Edoxaban (Savaysa®) Daiichi Sankyo N/A N/A N/A
Rivaroxaban (Xarelto®) Johnson and Johnson Pharmacy Link Link

COPD
Inhalers
  • The three classes of inhaled COPD medications are beta agonists, corticosteroids, and antimuscarinics. Asthma inhalers contain one or a combination of these medications.
  • The table below contains PAP information for all the available COPD inhalers

Drug Manufacturer Ships to PAP info Application
Advair® diskus and HFA (fluticasone + salmeterol) GlaxoSmithKline Patient or other Link Link
Anoro Ellipta® (vilanterol + umeclidinium) GlaxoSmithKline Patient or other Link Link
Atrovent® HFA (ipratropium) Boehringer Ingelheim Patient Link Link
Bevespi Aerosphere® (formoterol + glycopyrrolate) AstraZeneca Patient or doctor Link Link
Breo Ellipta® (fluticasone + vilanterol) GlaxoSmithKline Patient or other Link Link
Combivent® (albuterol + ipratropium) Boehringer Ingelheim Patient Link Link
Duaklir Pressair® (aclidinium + formoterol) Circassia N/A N/A N/A
Incruse Ellipta® (umeclidinium) GlaxoSmithKline Patient or other Link Link
Proventil® HFA (albuterol) Merck Patient or doctor Link Link
ProAir® HFA and RespiClick (albuterol) Teva Patient or doctor Link Link
Serevent® (salmeterol) GlaxoSmithKline Patient or other Link Link
Spiriva® handihaler and Respimat (tiotropium) Boehringer Ingelheim Patient Link Link
Stiolto Respimat® (olodaterol + tiotropium) Boehringer Ingelheim Patient Link Link
Striverdi Respimat® (olodaterol) Boehringer Ingelheim Patient Link Link
Symbicort® (budesonide + formoterol) AstraZeneca Patient or doctor Link Link
Trelegy Ellipta® (fluticasone + umeclidinium + vilanterol) GlaxoSmithKline Patient or other Link Link
Tudorza Pressair® (aclidinium) Circassia N/A N/A N/A
Utibron Neohaler® (indacaterol and glycopyrrolate) Sunovion Pharmacy Link Link
Ventolin® (albuterol) GlaxoSmithKline Patient or other Link Link

Crohn's disease
  • Six biologics are approved to treat Crohn's disease: Adalimumab (Humira®), Certolizumab (Cimzia®), Infliximab (Remicade®), Ustekinumab (Stelara®), Vedolizumab (Entyvio®), and Natalizumab (Tysabri®). I can help patients obtain Humira®, Cimzia®, and Stelara® (see PAP info below). The other 3 medications are given by IV infusion at a doctor's office.
  • Other treatments like azathioprine, mercaptopurine, and methotrexate have cheap generics

Patient Assistance Programs for Biologics in Crohn's Disease
Drug Manufacturer Ships to FPL limit PAP info Application
Adalimumab (Humira®) Abbvie Patient or doctor < 600% Link Link (online and pdf)
Certolizumab (Cimzia®) UHC Patient < 500% Link Link (online)
Ustekinumab (Stelara®) Janssen Pharmacy or Doctor < 400% Link Link (pdf)

Deep vein thrombosis (DVT)
Anticoagulants
  • Deep vein thrombosis is a condition where a blood clot forms in the deep vein of the legs. DVTs can lead to pulmonary embolisms so patients must be anticoagulated for treatment and prevention.
  • There are 5 anticoagulants that can be used for DVTs. Four of them are newer medications that do not require frequent lab monitoring, but they have no generics and are expensive. Warfarin is an older anticoagulant that is cheap and effective, but it sometimes requires frequent lab monitoring (PT/INR), especially upon initiation. The table below gives the PAP information for the 4 newer drugs.

Drug Manufacturer Ships to PAP info Application
Apixaban (Eliquis®) Bristol-Myers Squibb Patient or doctor Link Link
Dabigatran (Pradaxa®) Boehringer Ingelheim Patient Link Link
Edoxaban (Savaysa®) Daiichi Sankyo N/A N/A N/A
Rivaroxaban (Xarelto®) Johnson and Johnson Pharmacy Link Link

Diabetes
Insulin
  • There are 3 manufacturers who make insulin - Sanofi, Novo Nordisk, and Lilly. Each manufacturer has a program for free insulin through a patient assistance program (PAP). The Lilly program will ship the insulin to the patient's home and the other two only ship the insulin to the doctor's office. With telemedicine, only the Lilly program is practical.
  • Sanofi and Novo Nordisk also have $99/month insulin programs where patients can get any combination of the insulin products they manufacture for a flat $99/month. The Sanofi program allows for up to 10 products (vials and/or packages of pens) per month and the Novo Nordisk program only allows for up to 3 products. In April 2020, Lilly launched a program in response to the COVID-19 pandemic that offers monthly supplies of Lilly insulins for a flat $35 copay. The program is for patients both with and without commercial insurance.
  • Links to details on all of the programs are provided in the table below. All 3 manufacturers offer a basal and premeal insulin, so no matter what insulin product(s) you use, your insulin(s) can easily be switched to comparable products from another manufacturer. See the StraightHealthcare insulin chart for a list of insulins grouped by type. Also, Novolin NPH and Novolin R are sold at Walmart for $25 a vial, and any insulin regimen can be switched to these 2 products.

Insulin Reduced cost programs Free programs
Basaglar, Humalog,
Humulin N, Humulin R,
Humalog Mix 50/50, Humalog Mix 75/25
Lilly Insulin Value Program
  • Insurance: with and without
  • Cost: $35 for a month supply
  • Eligibility requirements: none
Lilly Cares program
  • Income < 400% of federal poverty level
  • U.S. legal resident
  • No insurance
Lantus, Toujeo, Admelog, Apidra Sanofi Insulin Value Savings Program
  • Insurance: without
  • Cost: $99/month for up to 10 packs of pens and/or vials
  • Eligibility requirements: none
Sanofi Patient Connection
  • Income < 400% of federal poverty level
  • U.S. legal resident
  • No insurance
Levemir, Tresiba, Novolog, Fiasp
Novolin N, Novolin R,
Novolin 70/30, Novolog Mix 70/30
My$99Insulin Program
  • Insurance: with and without
  • Cost: $99/month for up to 3 vials or 2 packs of pens
  • Eligibility requirements: none

Walmart (Novolin N, Novolin R, Novolin 70/30 only)
  • Insurance: with and without
  • Cost:
    • Novolin N - $25/vial and $43 for 5 pens
    • Novolin R - $25/vial
NovoCare Patient Assistance Program
  • Income < 400% of federal poverty level
  • U.S. legal resident
  • No insurance

SGLT2 inhibitors
  • The ADA now recommends SGLT2 inhibitors as second-line therapy after metformin in diabetics who have cardiovascular disease, heart failure, and/or chronic kidney disease. No SGLT2 inhibitor has a generic, and they are expensive.
  • Links to patient assistance programs for the four SGLT2 inhibitors that are currently available are in the table below. All the drugs with PAP programs will ship to a pharmacy or the patient's home.

Drug Manufacturer Ships to PAP info Application
Canagliflozin (Invokana®, Invokamet®, Invokamet® XR) Johnson and Johnson Pharmacy Link Link
Dapagliflozin (Farxiga®, Qtern®, Xigduo XR®) AstraZeneca Patient or doctor Link Link
Empagliflozin (Jardiance®, Glyxambi®,Synjardy®, Synjardy® XR) Boehringer Ingelheim Patient Link Link
Ertugliflozin (Steglatro®) Merck N/A N/A N/A

GLP-1 analogs
  • The ADA now recommends GLP-1 analogs as second-line therapy after metformin in diabetics who have cardiovascular disease. No GLP-1 analog has a generic, and they are expensive.
  • Links to patient assistance programs for all GLP-1 analogs are listed below.

Drug Manufacturer Ships to PAP info Application
Albiglutide (Tanzeum™) GlaxoSmithKline Patient or other Link Link
Dulaglutide (Trulicity™) Lilly Patient or doctor Link Link
Exenatide (Bydureon®, Byetta®) AstraZeneca Patient or doctor Link Link
Liraglutide (Victoza®) Novo Nordisk Doctor Link Link
Liraglutide (Saxenda®) Novo Nordisk Doctor Link Link
Lixisenatide (Adlyxin®) Sanofi Doctor Link Link
Semaglutide (Ozempic®) Novo Nordisk Doctor Link Link
Semaglutide (Rybelsus®) Novo Nordisk Doctor Link Link
DPP-4 inhibitors
  • DPP-4 inhibitors are a class of drugs used to treat type 2 diabetes. Alogliptin is the only DPP-4 inhibitor that has a generic.
  • Links to patient assistance programs for all DPP-4 inhibitors are listed below.

Drug Manufacturer Ships to PAP info Application
Alogliptin (Nesina®, Oseni®, Kazano®) Takeda Patient or doctor Link Link
Linagliptin (Tradjenta®, Glyxambi®,Jentadueto®,Jentadueto® XR) Boehringer Ingelheim Patient Link Link
Saxagliptin (Onglyza®, Kombiglyze® XR, Qtern®) AstraZeneca Patient or doctor Link Link
Sitagliptin (Januvia®, Janumet®, Janumet® XR) Merck Patient or doctor Link Link

High cholesterol
  • High cholesterol is typically treated with a class of drugs called statins which has many cheap generics. A new class of highly effective injectable drugs called PCSK9 inhibitors has also become available. There are two drugs in the class and they are very expensive. PAP information for the two drugs is provided below.

Drug Manufacturer Ships to PAP info Application
Alirocumab (Praluent®) Regeneron Patient or pharmacy Link Link
Evolocumab (Repatha®) Amgen Patient Link Link

Hepatitis C
  • There are currently 6 medications available to treat hepatitis C. Treatment recommendations vary by hepatitis C genotype, degree of liver disease, and previous treatment. See hepatitis C treatment for more.
  • The table below contains PAP information for the 6 hepatitis C medications

Drug Manufacturer Ships to PAP info Application
Epclusa® (sofosbuvir + velpatasvir) Gilead Patient or doctor Link Link
Harvoni® (sofosbuvir + ledipasvir) Gilead Patient or doctor Link Link
Mavyret™ (glecaprevir + pibrentasvir) Abbvie Patient or doctor Link Link
Viekira Pak™ (ombitasvir + paritaprevir + dasabuvir + ritonavir) Abbvie N/A N/A N/A
Vosevi™ (sofosbuvir + velpatasvir + voxilaprevir) Gilead Patient or doctor Link Link
Zepatier® (elbasvir + grazoprevir) Merck Patient or doctor Link Link

Migraine headache
  • Medications approved to treat migraine headaches have expanded recently. Older drugs (e.g. triptans) typically have cheaper generics, but the newer drugs do not. (see migraine headache medications for more)
  • The table below lists the PAP information for some of the newer therapies and a few of the older ones

Drug Manufacturer Ships to PAP info Application
Erenumab (Aimovig®) Amgen Patient Link Link
Galcanezumab (Emgality™) Lilly Patient or doctor Link Link
Lasmiditan (Reyvow®) Lilly Patient or doctor Link Link
Sumatriptan (Imitrex® nasal spray) GlaxoSmithKline Patient or other Link Link
Rizatriptan (Maxalt®) Merck Patient or doctor Link Link
Ubrogepant (Ubrevly®) Allergen Doctor Link Link

Pulmonary embolism (PE)
Anticoagulants
  • Pulmonary embolism is a condition where a blood clot in the venous system travels through the circulation and lodges in the lung tissue. Pulmonary embolisms can be life-threatening so patients must be anticoagulated for treatment and prevention.
  • There are 5 anticoagulants that can be used for PEs. Four of them are newer medications that do not require frequent lab monitoring, but they have no generics and are expensive. Warfarin is an older anticoagulant that is cheap and effective, but it sometimes requires frequent lab monitoring (PT/INR), especially upon initiation. The table below gives the PAP information for the 4 newer drugs.

Drug Manufacturer Ships to PAP info Application
Apixaban (Eliquis®) Bristol-Myers Squibb Patient or doctor Link Link
Dabigatran (Pradaxa®) Boehringer Ingelheim Patient Link Link
Edoxaban (Savaysa®) Daiichi Sankyo N/A N/A N/A
Rivaroxaban (Xarelto®) Johnson and Johnson Pharmacy Link Link

Pre-exposure prophylaxis (PrEP) for HIV
Truvada® and Descovy®
  • Two drugs are approved for HIV PrEP therapy - Truvada® and Descovy®. Both are made by Gilead and they fall under the same PAP.

Drug Manufacturer Ships to PAP info Application
Truvada® and Descovy® (emtricitabine and tenofovir) Gilead Pharmacy Link PDF
Online

Psoriasis and Psoriatic arthritis
  • A number of biologic medications are now approved to treat psoriasis and psoriatic arthritis. The tables below contain PAP information for these medications. Information for apremilast (Otezla®), a nonbiologic systemic therapy, is also provided.

Patient Assistance Programs for Tumor Necrosis Factor Inhibitors
Drug Manufacturer Approval Ships to FPL limit PAP info Application
Adalimumab (Humira®) Abbvie PP/PA Patient or doctor < 600% Link Link (online and pdf)
Certolizumab (Cimzia®) UHC PP/PA Patient < 500% Link Link (online)
Etanercept (Enbrel®) Amgen PP/PA Patient < 500% Link Link (pdf)
Golimumab (Simponi®) Janssen PA Pharmacy < 400% Link Link (pdf)
Infliximab (Remicade®) Janssen PP/PA IV infusion
Doctor's office
< 400% Link Link (pdf)

Patient Assistance Programs for IL-17, IL-23, and IL-12/23 Inhibitors
Drug Manufacturer Approval Ships to FPL limit PAP info Application
Brodalumab (Siliq®) Ortho PP Patient < 400% Link Link (pdf)
Ixekizumab (Taltz®) Lilly PP/PA Patient or Doctor < 500% Link Link (online and pdf)
Secukinumab (Cosentyx®) Novartis PP/PA Patient < 570% Link Link (pdf)
Guselkumab (Tremfya®) Janssen PP/PA Pharmacy < 400% Link Link (pdf)
Risankizumab (Skyrizi®) Abbvie PP Patient or Doctor < 600% Link Link (online and pdf)
Tildrakizumab (Ilumya™) Sun Pharma PP Doctor < 400% Link Link (pdf)
Ustekinumab (Stelara®) Janssen PP/PA Pharmacy or Doctor < 400% Link Link (pdf)

Apremilast (Otezla®) Patient Assistance Program
Drug Manufacturer Approval Ships to FPL limit PAP info Application
Apremilast (Otezla®) Amgen PP/PA Patient < 392% Link Link (pdf)